"In silico drug repositioning of FDA-approved drugs to predict new ..."

Sedighe Sadat Jafaripour et al. (2020)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOLCHEM.2020.107308

access: closed

type: Journal Article

metadata version: 2022-06-23

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/candc/JafaripourGNHS20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/candc/JafaripourGNHS20
Sedighe Sadat Jafaripour, Sajjad Gharaghani, Elmira Nazarshodeh, Shozeb Haider, Ali Akbar Saboury:
In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation. Comput. Biol. Chem. 88: 107308 (2020)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.